IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Evogene LTD (EVGN)

CUSIP: M4119S904 | Healthcare · Biotechnology | Micro Cap | 3 institutional holders

Quarters

Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile